VLDLR and Abnormal retinal morphology: More importantly, autophagy agonists HPβCD and trehalose robustly reduced the number of pathological RAP-like lesions in Vldlr–/– retinas (Figure 7E and Supplemental Figure 7, F and G), offering a potentially novel therapeutic target to alleviate neovascular retinal disease.